Antimicrobial Chemotherapy for Legionnaires Disease: Levofloxacin versus Macrolides
Open Access
- 15 March 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (6) , 800-806
- https://doi.org/10.1086/428049
Abstract
Background. The community outbreak of legionnaires disease that occurred in Murcia, Spain, in July 2001—to our knowledge, the largest such outbreak eKeywords
This publication has 35 references indexed in Scilit:
- Legionnaires' disease: a rational approach to therapyJournal of Antimicrobial Chemotherapy, 2003
- Legionella pneumophila Pneumonia Successfully Treated with Intravenous Ciprofloxacin.Internal Medicine, 2002
- In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumoniaJournal of Antimicrobial Chemotherapy, 1996
- Antimicrobial Chemotherapy for Legionnaires' Disease: A ReviewClinical Infectious Diseases, 1995
- Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophilaAntimicrobial Agents and Chemotherapy, 1995
- Rote of the quinolones in the treatment of legionellosisJournal of Antimicrobial Chemotherapy, 1991
- Comparison of the activity of three antibiotic regimens in severe Legionnaires' diseaseJournal of Antimicrobial Chemotherapy, 1990
- Brief report: Ciprofloxacin in the treatment of legionellosis in critically III patients including those cases unresponsive to erythromycinThe American Journal of Medicine, 1989
- Ciprofloxacin: a preferred treatment for legionella infections in patients receiving cyclosporin AJournal of Antimicrobial Chemotherapy, 1988
- Legionnaires' DiseaseNew England Journal of Medicine, 1977